English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu“Just understanding the immune responses to these vaccines will help us integrate what is successful into vaccine designs going forward.”
Tag: Johnson & Johnson
AACN Releases Innovative Teaching Tool Designed to Inspire Nurses to Practice with Moral Courage and Compassion
AACN, in collaboration with Johnson & Johnson Services, Inc., is pleased to announce the release of the Trailblazing Innovation Faculty Tool Kit, developed to help prepare future nurses to serve as leaders, advocates, problem-solvers, and risk-takers throughout the healthcare system. This teaching resource centers on the themes highlighted in the award-winning documentary 5B, which provides a powerful look at the tremendous impact nurses can have on responding to public health threats, providing care to patients and communities at risk, and implementing new standards of care
Rutgers Expert Available to Discuss Mixing and Matching of COVID-19 Vaccines, Booster Shots
Rutgers infectious disease expert Shobha Swaminathan is available to discuss the mixing and matching of COVID-19 vaccines and boosters as the Food and Drugs Administration authorized booster shots for both the Johnson & Johnson and Moderna vaccines. “There is mounting…
GW Expert Available to Discuss the Importance of Sunscreen after J&J Recall
Johnson & Johnson voluntarily recalled several of its aerosol sunscreen products recently after discovering trace amounts of a potential carcinogen in samples. While the levels detected were low, the company suggests consumers should stop using the products and throw them…
Data and safety review board reports how it monitored the COVID-19 vaccine trials
Evaluation of three vaccine candidates during the COVID-19 pandemic fell to 12 experts of the federally appointed COVID-19 Vaccine Data and Safety Monitoring Board. This team has now taken the unusual step of publishing details of their review process in The Journal of Infectious Diseases.
Johnson & Johnson and AACN Announce New Initiative Focused on Embedding Innovation in Nursing Curriculum
To spotlight the impact nurses have on leading innovation and advancing new models of care the American Association of Colleges of Nursing (AACN) is creating new teaching tools designed to inspire the next generation of nurses to serve with courage, ingenuity, and compassion.
6 important things to know about your COVID-19 vaccine card
Everyone who gets vaccinated for COVID-19 in the U.S. receives a vaccine card. Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York, offers insight into why vaccine cards are important and why you…
A Johns Hopkins University health care expert is available to offer perspective on the news that a mistake at a Johnson & Johnson factory producing the COVID-19 vaccine resulted in the loss of millions of doses.
A Johns Hopkins University health care expert is available to offer perspective on the news that a mistake at a Johnson & Johnson factory producing the COVID-19 vaccine resulted in the loss of millions of doses. Tinglong Dai is an…
FAU Expert Answers Questions about COVID-19 Vaccines
FAU’s Joanna Drowos, D.O., M.P.H., M.B.A., provides answers to some of the most frequently asked questions regarding COVID-19 vaccines.
Behind the Scenes at a COVID-19 Vaccine Trial
The principal investigators of the Moderna and Johnson & Johnson COVID-19 vaccine clinical trials at Rutgers discuss how the university became a site and their challenges and successes. The Rutgers J&J trial site was the second-largest clinical trial for the company.
Rutgers University’s Resilient, Innovative Year Confronting COVID-19
The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.
Johnson & Johnson Seeks FDA Emergency Use Authorization for COVID-19 Vaccine
Rutgers was the second-largest Phase 3 clinical research trial site for Johnson & Johnson’s COVID-19 vaccine, which applied for emergency use authorization today from the U.S. Food and Drug Administration.
American Dental Hygienists’ Association Teams Up with Walgreens and Johnson & Johnson for National Dental Hygiene Month
Details on the groundbreaking partnership between ADHA, Johnhon & Johnson and Walgreens taking place during October